# 💉 WIA-BIO-016: Biopharma Standard

[![Version](https://img.shields.io/badge/version-1.0.0-blue.svg)]()
[![License](https://img.shields.io/badge/license-MIT-green.svg)]()
[![Standard](https://img.shields.io/badge/WIA-Standard-purple.svg)]()


> **Standard ID:** WIA-BIO-016
> **Version:** 1.0.0
> **Status:** Active
> **Category:** BIO (Biotechnology / Life Sciences)
> **Color:** Teal (#14B8A6)

---

## 🌟 Overview

The WIA-BIO-016 standard defines the comprehensive framework for biopharmaceutical development, characterization, manufacturing, and regulatory compliance, including monoclonal antibodies, vaccines, recombinant proteins, and biosimilars.

**홍익인간 (弘益人間) - Benefit All Humanity** - This standard aims to provide a scientifically-grounded foundation for developing life-saving biopharmaceuticals while ensuring safety, efficacy, and accessibility for all.

## 🎯 Key Features

- **Monoclonal Antibodies (mAbs)**: Design, production, and characterization of therapeutic antibodies
- **Vaccines**: Development and testing of biological vaccines including mRNA, viral vector, and protein-based
- **Recombinant Proteins**: Expression systems and purification protocols for therapeutic proteins
- **Biosimilars**: Development pathway for biosimilar products
- **Antibody-Drug Conjugates (ADCs)**: Design and characterization of targeted therapies
- **Regulatory Compliance**: FDA BLA, EMA MAA, and international regulatory pathways

## 📊 Core Concepts

### 1. Binding Affinity (Kd)

```
Kd = [Ab][Ag] / [Ab-Ag]
```

Where:
- `Kd` = Dissociation constant (M)
- `[Ab]` = Free antibody concentration
- `[Ag]` = Free antigen concentration
- `[Ab-Ag]` = Antibody-antigen complex concentration

### 2. Pharmacokinetic Parameters

```
AUC = (Dose × F) / CL
```

Where:
- `AUC` = Area under curve (mg·h/L)
- `Dose` = Administered dose (mg)
- `F` = Bioavailability (0-1)
- `CL` = Clearance (L/h)

### 3. Immunogenicity Risk Score

```
IRS = (ADA_rate × Severity × Duration) / Tolerance
```

Where:
- `IRS` = Immunogenicity risk score
- `ADA_rate` = Anti-drug antibody incidence (0-1)
- `Severity` = Clinical impact score (1-10)
- `Duration` = Treatment duration factor
- `Tolerance` = Patient tolerance factor

## 🔧 Components

### TypeScript SDK

```typescript
import {
  calculateBindingAffinity,
  validateDrugCandidate,
  assessImmunogenicity,
  simulatePharmacokinetics
} from '@wia/bio-016';

// Calculate antibody binding affinity
const affinity = calculateBindingAffinity({
  antibodyConc: 1e-9, // 1 nM
  antigenConc: 1e-8, // 10 nM
  complexConc: 0.9e-9, // 0.9 nM
  temperature: 37 // °C
});

// Validate drug candidate
const validation = validateDrugCandidate({
  drugType: 'monoclonal-antibody',
  targetAffinity: 1e-9, // nM
  stability: 0.95,
  immunogenicityRisk: 'low'
});

console.log(validation.isValid, validation.recommendations);
```

### CLI Tool

```bash
# Calculate binding affinity
wia-bio-016 calc-affinity --ab-conc 1e-9 --ag-conc 1e-8

# Validate drug candidate
wia-bio-016 validate --type mab --affinity 1e-9 --stability 0.95

# Assess immunogenicity
wia-bio-016 immunogenicity --ada-rate 0.05 --severity 3

# Simulate pharmacokinetics
wia-bio-016 simulate-pk --dose 100 --clearance 0.2 --volume 5
```

## 📚 Documentation

| Document | Description |
|----------|-------------|
| [WIA-BIO-016-v1.0.md](./spec/WIA-BIO-016-v1.0.md) | Complete specification with biopharmaceutical theory |
| [TypeScript SDK](./api/typescript/) | Full TypeScript implementation |
| [CLI Tool](./cli/wia-bio-016.sh) | Command-line interface |

## 🚀 Quick Start

### Installation

```bash
# Clone repository
git clone https://github.com/WIA-Official/wia-standards.git
cd wia-standards/standards/biopharma

# Run installation script
./install.sh

# Verify installation
wia-bio-016 --version
```

### TypeScript Usage

```bash
# Install via npm
npm install @wia/bio-016

# Or yarn
yarn add @wia/bio-016
```

```typescript
import { BiopharmaSDK } from '@wia/bio-016';

const sdk = new BiopharmaSDK();

// Calculate binding affinity
const result = sdk.calculateBindingAffinity({
  antibodyConc: 1e-9,
  antigenConc: 1e-8,
  complexConc: 0.9e-9,
  temperature: 37
});

console.log(`Kd: ${result.kd.toExponential()} M`);
console.log(`Binding strength: ${result.bindingStrength}`);
```

## 🔬 Biopharmaceutical Classes

| Class | Examples | Molecular Weight | Half-Life |
|-------|----------|------------------|-----------|
| Monoclonal Antibodies | Rituximab, Trastuzumab | ~150 kDa | 14-21 days |
| Antibody Fragments | Fab, scFv | ~50 kDa | 1-3 days |
| Fusion Proteins | Etanercept, Abatacept | 100-200 kDa | 3-7 days |
| Cytokines | Interferons, Interleukins | 15-25 kDa | Hours to days |
| Enzymes | Asparaginase, Tissue plasminogen activator | 50-70 kDa | Variable |
| Vaccines | mRNA, Viral vector, Protein | Variable | N/A |

## ⚠️ Quality Considerations

1. **Purity**: ≥95% by HPLC/SEC
2. **Potency**: Within 80-120% of reference standard
3. **Stability**: Maintain activity for ≥24 months at 2-8°C
4. **Aggregation**: <5% by SEC
5. **Endotoxin**: <1 EU/mg for parenteral products
6. **Immunogenicity**: ADA incidence <10% in clinical trials

## 🌐 WIA Integration

This standard integrates with:
- **WIA-INTENT**: Intent-based drug discovery queries
- **WIA-OMNI-API**: Universal biopharmaceutical API gateway
- **WIA-SOCIAL**: Clinical trial coordination and patient engagement
- **WIA-QUANTUM**: Molecular dynamics simulations

## 📖 Use Cases

1. **Cancer Therapy**: Monoclonal antibodies targeting tumor antigens
2. **Autoimmune Diseases**: TNF-α inhibitors, IL-6 blockers
3. **Rare Diseases**: Enzyme replacement therapies
4. **Infectious Diseases**: Therapeutic antibodies, vaccines
5. **Biosimilar Development**: Cost-effective alternatives to biologics

## 🤝 Contributing

Contributions welcome! Please see our [Contributing Guide](https://github.com/WIA-Official/wia-standards/CONTRIBUTING.md).

## 📄 License

MIT License - see [LICENSE](https://github.com/WIA-Official/wia-standards/LICENSE)

## 🔗 Links

- **Website**: [wiastandards.com](https://wiastandards.com)
- **GitHub**: [github.com/WIA-Official/wia-standards](https://github.com/WIA-Official/wia-standards)
- **Documentation**: [docs.wiastandards.com](https://docs.wiastandards.com)
- **Certification**: [cert.wiastandards.com](https://cert.wiastandards.com)

---

**홍익인간 (弘益人間) · Benefit All Humanity**

*WIA - World Certification Industry Association*
*© 2025 SmileStory Inc. / WIA*
*MIT License*

---

**홍익인간 (弘益人間) - Benefit All Humanity** 🌍
